June 25, 2024
FDA has established a public docket to receive information, recommendations, and comments on matters related to the Agency’s regulation of compounding of human drug products under […]
June 25, 2024
MONTREAL —Tirzepatide (Mounjaro, Eli Lilly), the dual gastric inhibitory polypeptide–glucagon-like peptide 1 (GIP–GLP-1) receptor agonist that has shown significant benefits in diabetes and obesity, may also […]
June 25, 2024
Share on PinterestNew research finds that ketamine may be a more effective treatment for severe depression than electroconvulsive therapy. damircudic/Getty Images A new study compares ketamine […]
June 25, 2024
Please note: Section 503A has been amended by the Compounding Quality Act, as described in Section 106(a) of the Act, and these amendments are not reflected […]
June 25, 2024
TITLE I–DRUG COMPOUNDING SEC. 101. SHORT TITLE. This Act may be cited as the “Compounding Quality Act”. SEC. 102. VOLUNTARY OUTSOURCING FACILITIES. (a) In General.–Subchapter A of […]
June 25, 2024
BACKGROUND Pharmaceutical compounding is the combining, mixing, or altering of ingredients to create a customized medication for an individual patient in response to a licensed practitioner’s […]
June 25, 2024
For Immediate Release: June 25, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On Monday, […]
June 25, 2024
Click on a frequently asked question about aspirin to jump to the answer. What are the different uses for aspirin? Strokes: Aspirin use recommended in both […]
June 25, 2024
Only a health care provider can determine whether regular use of aspirin will help to prevent a heart attack or stroke in your particular case. Aspirin […]
Prev page
123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435436437438439440441442443444445446447448449450451452453454455456457458459460461462463464465466467468469470471472473474475476477478479480481482483484485486487488489490491492493494495496497498499500501502503504505506507508509510511512513514515516517518519520521522523524525526527528529530531532533534535536537538539540541542543544545546547548549550551552553554555556557
Next page